ElevateBio

Cell and Gene Therapy Innovation Right From The Start

Elevated Insights

From gene editing to biomanufacturing, learn more about the cell and gene therapy industry from our team of industry-leading experts

Reflecting on ElevateBio’s First Five Years

From our Chairman and CEO, David Hallal

View Insight

ElevateBio’s Lentiviral Vector Platform: Right the first time

By: Mercedes Segura, Vice President, Process Development, ElevateBio, Dawn Maier, Vice President, Emerging Technologies, ElevateBio, and Bojiao Yin, Director of Vector Process Development, ElevateBio

View Insight

Right from the start: Successfully managing the life cycles of cell and gene therapies

By Mike Paglia, Chief Operating Officer ElevateBio BaseCamp

View Insight

The Medicines of Tomorrow: A primer on the gene editing landscape

By Adrian Oliver, Ph.D., Senior Scientist of Technology Development, Life Edit Therapeutics

View Insight

Addressing Gaps in Cystic Fibrosis Treatment by Fixing Nonsense Mutations

By Alexandra Crawley, PH.D., Co-founder and Principal Investigator, Life Edit Therapeutics, Inc.

View Insight